Atorvastatin reduces renal interstitial fibrosis caused by unilateral ureteral obstruction through inhibiting the transcriptional activity of YAP
- 16 August 2023
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 678, 109-114
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81960168, 82060067)
This publication has 20 references indexed in Scilit:
- Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Kidney Fibrosis2016
- Influence of Expression Plasmid of Connective Tissue Growth Factor and Tissue Inhibitor of Metalloproteinase-1 shRNA on Hepatic Precancerous Fibrosis in RatsAsian Pacific Journal of Cancer Prevention, 2015
- Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathyAmerican Journal of Physiology-Renal Physiology, 2015
- The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathyBasic Research in Cardiology, 2014
- Metabolic control of YAP and TAZ by the mevalonate pathwayNature Cell Biology, 2014
- Comparative effects of statins on murine cardiac gene expression profiles in normal miceEuropean Journal of Pharmacology, 2013
- Renal interstitial fibrosisCurrent Opinion in Nephrology and Hypertension, 2012
- The role of EMT in renal fibrosisCell and tissue research, 2011
- Role of YAP/TAZ in mechanotransductionNature, 2011
- The renal cortical fibroblast in renal tubulointerstitial fibrosisThe International Journal of Biochemistry & Cell Biology, 2006